Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
USD 1.97
(51.54%)
USD 1.97
(51.54%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.5 Billion CNY | 3.38% |
| 2022 | 1.45 Billion CNY | -63.89% |
| 2021 | 4.02 Billion CNY | 152.36% |
| 2020 | 1.59 Billion CNY | 105.77% |
| 2019 | 775.08 Million CNY | 82885.97% |
| 2018 | 934 Thousand CNY | -18.64% |
| 2017 | 1.14 Million CNY | -69.44% |
| 2016 | 3.75 Million CNY | 30.14% |
| 2015 | 2.88 Million CNY | -50.24% |
| 2014 | 5.8 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 405.25 Million CNY | 7.5% |
| 2024 Q1 | 52.14 Million USD | -24.58% |
| 2024 Q3 | 67.12 Million USD | 16.11% |
| 2023 Q2 | 58.31 Million USD | 58.88% |
| 2023 Q4 | 70.56 Million USD | 110.54% |
| 2023 Q3 | -669.7 Million CNY | -1248.46% |
| 2023 FY | 1.5 Billion CNY | 3.38% |
| 2023 Q1 | 36.7 Million USD | -97.47% |
| 2022 Q2 | 47.66 Million USD | -51.46% |
| 2022 Q4 | 1.45 Billion CNY | 253.64% |
| 2022 FY | 1.45 Billion CNY | -63.89% |
| 2022 Q3 | -946.04 Million CNY | -2084.64% |
| 2022 Q1 | 98.2 Million USD | -51.81% |
| 2021 Q1 | 248.61 Million USD | 0.0% |
| 2021 FY | 4.02 Billion CNY | 152.36% |
| 2021 Q4 | 203.79 Million USD | 119.18% |
| 2021 Q3 | 92.98 Million USD | 20.89% |
| 2021 Q2 | 76.91 Million USD | -69.06% |
| 2020 FY | 1.59 Billion CNY | 105.77% |
| 2019 FY | 775.08 Million CNY | 82885.97% |
| 2018 FY | 934 Thousand CNY | -18.64% |
| 2017 FY | 1.14 Million CNY | -69.44% |
| 2016 FY | 3.75 Million CNY | 30.14% |
| 2015 FY | 2.88 Million CNY | -50.24% |
| 2014 FY | 5.8 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -246816.725% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -366228.185% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -8147.612% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -1984145.418% |
| Biomind Labs Inc. | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 89.772% |
| CytoDyn Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -77671.739% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -635066.554% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -1122.044% |
| SQZ Biotechnologies Company | 21.47 Million USD | -6895.763% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -1517719.262% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -9426.089% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -2285912.05% |
| Mesoblast Limited | 5.9 Million USD | -25358.319% |
| Marizyme, Inc. | 645.81 Thousand USD | -232561.309% |
| Genus plc | 668.8 Million USD | -124.664% |
| Pharming Group N.V. | 245.31 Million USD | -512.496% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -1957339.325% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -3802091.406% |
| MultiCell Technologies, Inc. | 49.32 USD | -3046532746.715% |
| ONE Bio Corp. | 52.29 Million USD | -2773.153% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -2921.963% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -4976.697% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -269314.212% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -2146400.0% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -228077.677% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| Enzolytics Inc. | 52.79 Thousand USD | -2845854.239% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -22.526% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -1071298.012% |
| Genscript Biotech Corporation | 839.52 Million USD | -78.975% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -8526941.598% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -150497.459% |
| EV Biologics, Inc. | 48.9 Thousand USD | -3072599.387% |
| Q BioMed Inc. | 284.35 Thousand USD | -528311.968% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -3007.395% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -935.53% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -8905.175% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -150405305.405% |
| Resverlogix Corp. | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -243273.654% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -635066.554% |
| Affymax, Inc. | 1.36 Million USD | -109655.296% |
| Itoco Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -19190.666% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -317074.34% |
| SYBLEU INC | 11.69 Thousand USD | -12846599.726% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -11557976.923% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -3800552.603% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -45021.622% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -22443.886% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -144515.014% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -5731.296% |
| CSL Limited | 14.8 Billion USD | 89.848% |
| Cellectis S.A. | 755 Thousand USD | -198913.245% |